Together these data indicate that, by sequestering LRP16 in the cytoplasm, K18 can effectively inhibit estrogen-promoted cell-cycle progression of estrogen-sensitive MCF-7 breast cancer cells. The gene discussed is KRT18; the disease is breast carcinoma.